Pancreatic ductal adenocarcinoma (PDAC) is a devastating metastatic disease for which better therapies are urgently needed. Macrophages enhance metastasis in many cancer types; however, the role of macrophages in PDAC liver metastasis remains poorly understood. Here we found that PDAC liver metastasis critically depends on the early recruitment of granulin-secreting inflammatory monocytes to the liver. Mechanistically, we demonstrate that granulin secretion by metastasis-associated macrophages (MAMs) activates resident hepatic stellate cells (hStCs) into myofibroblasts that secrete periostin, resulting in a fibrotic microenvironment that sustains metastatic tumour growth. Disruption of MAM recruitment or genetic depletion of granulin reduced hStC activation and liver metastasis. Interestingly, we found that circulating monocytes and hepatic MAMs in PDAC patients express high levels of granulin. These findings suggest that recruitment of granulin-expressing inflammatory monocytes plays a key role in PDAC metastasis and may serve as a potential therapeutic target for PDAC liver metastasis.
Pancreatic cancer is among the most lethal cancers in part owing to its aggressive metastatic nature 1, 2 . Metastatic spreading is a multistage process, which starts with the dissemination of cancer cells from the primary tumour site and ends with clinically detectable metastatic outgrowth at distant organs. Tumours can release large numbers of cancer cells into the circulation, but only a small proportion of these cells are able to successfully survive and colonize the hostile environment at the distant metastatic site 3, 4 . Thus, the successful outgrowth of metastatic tumour cells in this new distant environment is a severe rate-limiting step during metastasis. Emerging evidence indicates that the colonization of a new organ by metastatic tumour cells critically depends on the support of non-cancerous stromal partners [5] [6] [7] [8] . Multiple steps of the metastatic cascade are supported by stromal partners, particularly macrophages and, in many cancers, metastasis correlates with increased macrophages at the metastatic site [9] [10] [11] [12] [13] [14] . PDAC is characterized by its formation of ductal structures and a rich stromal compartment containing mainly fibroblasts, stellate cells and infiltrating immune cells. In response to the presence of tumour cells, quiescent fibroblasts and stellate cells become activated myofibroblasts that express alpha smooth muscle actin 15 (αSMA) . In non-pathological conditions, myofibroblasts are critical for wound healing 16 . In cancer, the role of myofibroblasts is controversial at present. Previous studies have suggested that myofibroblasts support tumour growth and restrict the delivery of chemotherapeutic drugs to the tumour [17] [18] [19] . However, recent reports have shown that genetic depletion of myofibroblasts results in tumour progression and metastasis 20, 21 . Most pancreatic cancer studies have focused on the role of stromal partners at the primary site; however, the role of stromal cells at the secondary metastatic site, which for PDAC is most often the liver, remains poorly understood.
At the moment, the best treatment option for PDAC patients is resection of the pancreatic tumour, but, unfortunately, by the time PDAC patients are diagnosed, most (∼80%) present with non-resectable metastatic cancer. Moreover, more than 60% of the patients whose tumours are resected, relapse with distant hepatic recurrence within the first 24 months after surgery 22, 23 . Thus, a better understanding of the mechanisms underlying the metastatic process in pancreatic cancer is critical to improve treatment and patient outcome. Figure 1 Metastatic PDAC cells induce macrophage recruitment and activation of myofibroblasts in the liver. (a) Identification of pan-cytokeratin (CK) + metastatic pancreatic cancer cells, haematopoietic cells (CD45 + ), macrophages (CD68 + ) and myofibroblasts (αSMA + ) as predominant cell types in the hepatic metastatic microenvironment of pancreatic cancer by immunohistochemical analysis of human biopsies. Representative micrographs and quantification of the data are shown (n = 5 PDAC patients, n = 5 healthy subjects; five fields assessed per sample; mean ± s.e.m.; two-tailed unpaired t-test). HL, healthy liver; LM, liver metastasis; FOV, field of view. (b) Established metastatic nodules in the liver were processed 12 days post intrasplenic implantation of 1 × 10 6 KPCs and analysed by flow cytometry. Composition of intrametastatic leukocytes is shown as a percentage of CD45 + cells using the following definitions: B cells (CD45 + CD3 neg B220 + ); T cells (CD45 + B220 neg CD3 + ), NK cells (CD45 + B220 neg CD3 neg NK1.1 + ), neutrophils (CD11b + Ly6G + F4/80 neg ), MAMs (CD11b + F4/80 + ) (n = 4 healthy livers; n = 8 liver metastasis; data combine two independent experiments; mean ± s.e.m.; two-tailed unpaired t-test). (c) Representative immunofluorescence staining of myofibroblasts (αSMA + ) clustering around metastatic KPC luc/zsGreen (zsGreen) cancer cells in the liver at 5 and 12 days after implantation. Histogram: quantification of myeloid (CD11b + ) and myofibroblast (αSMA + ) cell frequency in livers during the course of metastasis formation. Nuclei were counterstained with DAPI (n = 6 mice per time point; four fields assessed per sample; data combine two independent experiments; mean ± s.e.m.; two-tailed unpaired t-test). (d) Representative Masson's trichrome staining (MTS) of tumour-bearing livers at 5 and 12 days after implantation. Histogram: quantification of area occupied by fibrotic stroma (n = 6 mice per time point; four fields assessed per sample; data combine two independent experiments; mean ± s.e.m.; two-tailed unpaired t-test). (e) Schematic of the generation of chimaeric mice resulting in tdTomatoRed-positive BM-derived macrophages and non-labelled resident Kupffer cells (KCs). (f) Chimaeric mice from e were intrasplenically implanted with 1 × 10 6 Panc02 cells and livers were collected after day 12. Immunofluorescence analysis of BM-derived tdTomatoRed + cells in combination with F4/80 staining and αSMA staining in tumour-bearing livers. Nuclei were counterstained with DAPI (data are from six mice per condition; one experiment). Scale bars, 100 µm; NS, not significant.
RESULTS

Metastatic PDAC cells trigger macrophage recruitment and an extensive stromal response in the liver
The most common route of PDAC metastasis is to the liver. To understand whether and how stromal cells influence liver PDAC metastasis, we first analysed liver biopsies from advanced metastatic PDAC patients and healthy volunteers by immunohistochemical and immunofluorescence techniques. We found that metastatic tumour cells (cytokeratin + ) are surrounded by an abnormal stromal compartment rich in haematopoietic immune cells (CD45 + ), macrophages (CD68 + ), myofibroblasts (αSMA + ; PDGFRα + ) and connective tissue deposition ( Fig. 1a and Supplementary Fig. 1a-c) . To further evaluate the type of immune cells accumulating at the metastatic site, we intrasplenically injected KPC-derived cells (FC1199), isolated from the genetically engineered mouse model of PDAC (Kras G12D ; Trp53 R172H ; Pdx1-Cre mice) 24 . In this model, tumour cells migrate to the liver through the portal circulation (a common way of metastasis occurring in humans) 25, 26 , and generate metastases restricted to the liver ( Supplementary Fig. 1d ). We analysed established metastatic tumours at day 12, by flow cytometry, and found that the percentages of CD45 + immune cells, B220 + B cells, CD3 + T cells, Nk1.1 + NK cells, CD11b + Ly6G + neutrophils, (a) Quantification of αSMA (Acta2), and collagen 1a (Col1a) mRNA levels in primary hStCs stimulated with isogenic macrophage-conditioned media (MCM) generated from WT or granulin-deficient (Grn −/− ) macrophages, and MCM generated from Grn −/− macrophages in the presence of recombinant granulin (rGranulin) as determined by qPCR (n = 3 independent experiments; mean ± s.e.m.; two-tailed unpaired t-test). (b) Quantification of hStC invasion towards MCM generated from WT or Grn −/− macrophages and MCM generated from Grn −/− macrophages in the presence of rGranulin (n = 3 independent experiments; mean ± s.e.m.; two-tailed unpaired t-test).
(c,d) The same as in a,b, but MCM was generated using in vivo-derived MAMs. Therefore, liver metastasis was induced by intrasplenic implantation of 1 × 10 6 KPC cells into isogenic WT + WT BM and WT + Grn −/− BM chimaeric mice (n = 3 independent experiments; mean ± s.e.m.; two-tailed unpaired t-test and F4/80 + macrophages were increased in tumour-bearing livers compared with tumour free livers ( Supplementary Fig. 2a -c). However, among the CD45 + immune cells, metastasis-associated macrophages (MAMs; CD11b + F4/80 + Ly6G neg CCR2 + ) were the most predominant cell population ( Fig. 1b , Supplementary Figs 2d and 3a,b). Interestingly, metastatic tumour cells initially induced a rapid accumulation of CD11b + F4/80 neg Ly6C + LY6G neg CCR2 + inflammatory monocytes (IMs) followed by an accumulation of MAMs ( Supplementary Fig. 3a ). In contrast, accumulation of αSMA + myofibroblasts and stromal expansion were detected only in established experimental and spontaneous metastatic lesions (Fig. 1c,d and Supplementary Fig. 3b -g). Macrophages in the liver can be broadly categorized into two classes: embryonically derived tissue-resident macrophages known as Kupffer cells (KCs), and infiltrating macrophages derived from IMs that originate from the bone marrow [27] [28] [29] [30] (BM). To investigate whether the increased number of MAMs we observe is due to an expansion of resident KCs or to the recruitment of BM-derived cells, we generated BM chimaeras by engrafting tdTomato red (tdTomato) BM into irradiated wild-type mice (WT + tdTomato + BM) or WT BM into irradiated WT mice (WT + WT BM). As KCs in the liver are radio-resistant 31 , they remain of host origin and are therefore F4/80 + tdTomato neg , whereas BM-derived macrophages are of donor origin and F4/80 + tdTomato + (Fig. 1e ). After confirming successful BM reconstitution ( Supplementary Fig. 3h ), chimaeric mice were intrasplenically implanted with the murine PDAC cell line Panc02 32 . We found that MAMs were exclusively tdTomato + , and, thus, derived from BM ( Fig. 1f and Supplementary Fig. 3i ). Conversely, in adjacent 'normal liver tissue' , F4/80 + macrophages remained tdTomato neg , consistent with resident F4/80 + KCs (Fig. 1f ). In addition, αSMA + metastasis-associated myofibroblasts remained tdTomato neg , suggesting that these cells are not of BM origin, but are locally activated mesenchymal cells, such as resident hepatic stellate cells (hStCs) or fibroblasts ( Fig. 1f and Supplementary Fig. 3j ). Granulin is highly expressed in hepatic metastatic lesions and metastasis-associated macrophages are the main source of granulin secretion. (a,b) Quantification of Grn mRNA levels (a) and granulin protein levels (b) in intrametastatic pancreatic cancer cells, immune-cell-depleted stromal cells (zsGreen neg CD45 neg ), and MAMs (CD45 + F4/80 + ) isolated by fluorescence-activated cell sorting from established tumour-bearing livers 12 days after intrasplenic implantation of 1 × 10 6 KPC luc/zsGreen cancer cells (a, data are from three pooled mice; one experiment; b, n = 3 independent experiments; mean ± s.e.m.; two-tailed unpaired t-test). (c) Quantification of Grn and Tgfb mRNA levels in tissue resident macrophages (KCs) and MAMs sorted from established metastatic lesions from chimaeric WT mice harbouring tdTomatoRed + BM as described in Fig. 1g (data are from three pooled mice; one experiment). (d) Spontaneous metastatic hepatic tumours derived from KPC mice were isolated and analysed. Representative images of immunohistochemistry staining for MAMs (CD68 + ) and granulin expression on serial tissue sections from metastatic lesions and healthy liver and quantification of the data (n = 5 control mice, n = 5 KPC mice, five fields assessed per sample; mean ± s.e.m.; two-tailed unpaired t-test). HL, healthy liver; LM, liver metastasis. (e) Representative images of immunohistochemistry staining for MAMs (CD68 + ) and granulin expression on serial tissue sections from human metastatic PDAC lesions and healthy liver and quantification of the data (n = 5 healthy subjects, n = 5 PDAC samples; five fields assessed per sample; mean ± s.e.m.; two-tailed unpaired t-test). Scale bars, 100 µm; asterisks indicate matched tissue areas.
Together, our findings demonstrate that: in PDAC liver metastasis, MAMs originate from IMs; MAMs represent the predominant immune cell population in metastatic liver lesions; and MAM accumulation in the liver precedes myofibroblast activation.
Macrophages promote myofibroblast activation and metastatic growth
To determine the functional role of MAMs in pancreatic cancer metastasis, we next intrasplenically implanted KPC cells into isogenic PI(3)Kγ −/− mice (p110γ −/− ) 33 and control WT mice. PI(3)Kγ is mainly expressed in the haematopoietic compartment, and PI(3)Kγ knockout mice have a defect in monocyte recruitment in response to inflammatory and tumour-derived signals 34, 35 . As we previously found that MAMs are IM-derived macrophages that are actively recruited from the BM to the metastatic liver ( Fig. 1f ), we reasoned that depletion of PI(3)Kγ will ablate IM trafficking to the metastatic site and consequently abolish MAM accumulation in the liver. Indeed, macrophage and IM numbers were significantly reduced in metastatic livers of PI(3)Kγ −/− mice compared with WT mice as measured by flow cytometry analysis ( Fig. 2a ). Importantly, PI(3)Kγ depletion markedly reduced metastatic frequency, average metastatic lesion size, and αSMA + myofibroblast numbers, in both KPC ( Fig. 2b-d and Supplementary Fig. 4a ) and Panc02 ( Supplementary Fig. 4b-e ) liver-metastasis-bearing mice. Together, these results suggest that inhibition of BM-derived macrophage recruitment to the liver prevents pancreatic cancer metastasis to the liver and is accompanied by a decrease in myofibroblast activation.
As most (∼80%) PDAC patients present with liver metastases at the time of diagnosis, or relapse with hepatic recurrence after surgical removal of primary pancreatic tumours 1 , we next focused our ANXA2  GREM1  P4HB  THBS1  LUM  FBN1  DCN  SPARC  CTSD  CCDC80  COL5A1  BGN  PPIB  EFEMP1  POSTN  HSPG2  EFEMP2  BMP1  TIMP1  COL4A2  MFAP2  PLEC  CTGF  LTBP1  COL5A2  TIMP2  ADAM9  COL6A1  LAMB1  LAMC1  LAMA1  ACTN1  PXDN  COL3A1  CYR61  COL1A2  COL6A3  COL12A1  LTBP4  SERPINE1  GSN  COL4A1  COL1A1  LOXL2  CST3  MMP2  COL4A5  FBLN1  VTN  SERPINF2  CD44  ECM1  SERPINH1  NID2  MMP1 studies on investigating whether MAMs are required for supporting the metastatic growth of already disseminated cancer cells. To address this question, we chemically depleted MAMs in vivo, using clodronate liposomes 36 (CLs). CL treatment was started at day 3 post intrasplenic injection of KPC cells, a time point in which initial seeding of the liver by KPC cells has already occurred ( Fig. 2e and Supplementary  Fig. 5a,b ). As expected, in response to CL treatment, MAM numbers were significantly reduced ( Fig. 2f and Supplementary Fig. 5c ). Interestingly, we could barely detect any αSMA + myofibroblasts in metastatic livers of CL-treated mice ( Fig. 2f and Supplementary  Fig. 5c ). The ablation of MAMs and the prevention of αSMA + myofibroblast accumulation was not cell line specific because similar results were observed using Panc02 cells ( Supplementary Fig. 5d,e ). Although the metastatic frequency was only modestly affected by CL treatment in both models, the size of the lesion area covered by metastatic cells was significantly reduced in response to macrophage depletion (Fig. 2g,h and Supplementary Fig. 5f ,g). Together, these results suggest that depletion of MAMs prevents the activation of myofibroblasts and impairs the progression of metastatic lesions even after initial colonization of the metastatic site by cancer cells.
Granulin secreted by macrophages triggers myofibroblast activation
We next sought to understand how MAMs regulate myofibroblast activation at the metastatic site. In this respect, we found that macrophage conditioned media (CM) acts as a strong activator of quiescent primary fibroblasts in culture and enhances their invasion and proliferation ( Supplementary Fig. 6a -c). To identify the macrophage-derived factors responsible for myofibroblast activation, we next exposed human THP-1 macrophages to the pancreatic cancer cell line Panc1 CM in vitro, and performed a secretome analysis. We identified several extracellular matrix (ECM) proteases associated with macrophage function [37] [38] [39] (Supplementary Tables 1 and 2) . Among the most highly secreted proteins we identified granulin (Grn), a secreted glycoprotein with a relative molecular mass of approximately 70,000 that has previously been shown to mediate wound healing, by stimulating fibroblast migration 40 , and to induce fibrosis in breast cancer 41 . As the main source of myofibroblasts in the liver is activated resident hStCs ( Supplementary Fig. 3j ) 16 , we next isolated primary hStCs from mice and stimulated them with CM generated from primary murine WT BM-derived macrophages or Grn −/− (granulin deficient) murine BM macrophages (BMMs). We found that CM generated from WT, but not from Grn −/− , BMMs efficiently activated isogenic hStCs and promoted their migration (Fig. 3a,b) . Importantly, addition of recombinant granulin to Grn −/− BMM CM was sufficient to restore hStC activation and migration ( Fig. 3a,b ). Next, we isolated MAMs from tumour-bearing livers derived from chimaeric WT + WT BM and WT + Grn −/− BM mice, and prepared MAM CM. We confirmed that only CM from WT MAMs efficiently induced hStC activation and migration, whereas CM from Grn −/− MAM was unable to induce activation or migration of hStCs ( Fig. 3c-e ). In addition, we found that granulin expression and secretion is increased in tumour-educated ( Fig. 3f ,g) and alternatively (M2-like) activated macrophages ( Supplementary  Fig. 6d,e ). Together, these data indicate that cancer-cell-derived factors induce the secretion of granulin in macrophages and that MAMs activate resident hStCs through granulin.
Granulin is highly expressed in pancreatic cancer metastatic lesions of mice and humans and MAMs are the main source of granulin in vivo.
In vivo, we found that within the metastatic tumour microenvironment, granulin is highly expressed in MAMs, and that MAMs are the main source of granulin secretion in metastatic lesions (Fig. 4a,b ). When we analysed chimaeric mice harbouring Once in the metastatic tissue, differentiated macrophages stimulate the activation and recruitment of resident hStCs through granulin secretion, resulting in excessive accumulation of myofibroblasts. Granulin-induced myofibroblasts release high levels of the ECM protein periostin, thereby enhancing survival and growth of metastatic pancreatic cancer cells in a hostile environment. Interruption of this sequence, by either preventing macrophage accumulation or by abolishing granulin expression in recruited macrophages, limits metastatic growth of pancreatic cancer cells.
tdTomatoRed BM, we found that BM-derived MAMs, but not resident KCs, express high levels of granulin (Grn) (Fig. 4c) . Surprisingly, expression levels of Tgfb, a common activator of hStCs 42 , were low in MAMs and KCs (Fig. 4c ). Finally, we further confirmed that granulin is highly expressed in the stroma of spontaneous hepatic metastatic lesions of human and murine tissues 24, 43 (Fig. 4d,e and Supplementary Fig. 6f ). Taken together, our findings indicate that granulin is highly expressed by MAMs and that MAMs are the main source of granulin in PDAC liver metastasis.
Depletion of granulin prevents liver fibrosis and PDAC metastatic growth
To investigate whether granulin is required for PDAC metastatic progression in vivo, we next inoculated Grn −/− and WT mice with isogenic KPC cells through intrasplenic implantation. We observed that lack of granulin expression did not alter metastatic frequency because WT and Grn −/− mice showed similar numbers of metastatic nodules (Fig. 5a,b) . However, the area covered by metastatic tumour cells in Grn −/− mice was significantly smaller compared with WT, resulting in an overall significant decrease of hepatic metastatic tumour burden (Fig. 5a,c) . Whereas depletion of granulin did not reduce the total number of MAMs (Fig. 5d ), nor their polarization at the metastatic site ( Supplementary Fig. 7a ), granulin deficiency abolished the accumulation of activated myofibroblasts in metastatic liver lesions (Fig. 5d ). Quantitative gene expression analysis of myofibroblast activation markers (Acta2, Fn, Col1a1) 16 further confirmed that lack of granulin prevents the activation of intrametastatic hStCs into myofibroblasts in vivo (Fig. 5e ).
Next, we characterized metastatic pancreatic tumour growth in WT mice transplanted with BM from Grn −/− or WT animals. We found that depletion of granulin in the haematopoietic compartment was sufficient to suppress metastatic growth of KPC cells (Fig. 5f,g) and to prevent myofibroblast activation in vivo (Fig. 5h,i) , while MAM numbers and polarization remained unchanged ( Fig. 5j and Supplementary Fig. 7b ). Interestingly, ablation of granulin in the haematopoietic compartment markedly reduced the number of proliferating (Ki67 + ) metastatic pancreatic tumour cells (Fig. 5k ), but apoptotic (cleaved caspase 3 + ) tumour cell numbers remained unchanged (Fig. 5l ). Taken together, these results suggest that granulin secretion by MAMs is required for hStCs activation and for metastatic growth of pancreatic tumours in the liver.
Granulin induces periostin expression in hStCs thereby allowing tumour growth Next, we sought to gain a better understanding of how MAM-induced myofibroblast activation promotes pancreatic cancer cell growth. To address this question, we stimulated human fibroblasts with macrophage CM and performed a mass spectrometry quantitative analysis of the secretome from fibroblasts exposed to macrophage CM compared with unexposed fibroblasts. We found that macrophage CM induces fibroblast secretion of proteins associated with ECM remodelling ( Fig. 6a and Supplementary Table 3 ), and in particular the secretion of the ECM component periostin (Fig. 6b ). Periostin has been reported to enhance metastatic growth of breast and colon cancer cells through activation of Wnt and α v β 3 -Akt/PKB signalling pathways, respectively 8, 44 . Thus, we next tested whether periostin expression by activated myofibroblasts is necessary to promote pancreatic cancer cell survival and growth. We found that myofibroblast CM markedly promoted colony formation and proliferation of PDAC cancer cells, and that addition of a periostinneutralizing antibody completely abolished these effects ( Fig. 6c and Supplementary Fig. 7c ). We confirmed that periostin acts in a paracrine myofibroblast-tumour cell loop because we did not detect any periostin expression in PDAC cells ( Supplementary Fig. 7d ). Moreover, we found that periostin was markedly upregulated in spontaneous hepatic metastatic lesions of human and murine tissues compared with healthy control livers ( Fig. 6d and Supplementary  Fig. 7e ). Importantly, the induction of periostin expression in primary hStCs was strictly dependent on granulin, because CM generated from Grn −/− BMM (Fig. 7a) and MAMs (Fig. 7b,c) was unable to induce periostin expression in hStCs. To examine whether inhibition of myofibroblast activation by MAM-derived granulin also affects periostin expression and stroma expansion in vivo, we analysed metastatic liver tissue sections of WT, PI(3)Kγ −/− , Grn −/− , WT + Grn −/− BM, and WT + CL-treated mice. In all models, hepatic periostin expression levels and connective tissue deposition were found to be significantly reduced compared with metastasisbearing WT control animals (Fig. 7d,e and Supplementary Fig. 7f,g) . In agreement with these findings, we found that intrametastatic myofibroblasts isolated from Grn −/− and WT + Grn −/− BM mice showed an approximately threefold reduction in periostin expression relative to control myofibroblasts isolated from WT tumour lesions (Fig. 7f ). Taken together, these findings indicate that MAMs induce the expression of ECM proteins in myofibroblasts, particularly periostin, in a granulin-dependent manner which then supports metastatic pancreatic tumour growth.
Although less frequently, PDAC can also sometimes metastasize to the lung 1 . Similar to what we observed in the liver, granulin was markedly expressed in the stromal compartment of pulmonary metastatic lesions, especially in areas rich in CD68 + macrophages ( Supplementary Fig. 8a ). Depletion of granulin in the haematopoietic compartment (WT + Grn −/− BM) was sufficient to reduce pulmonary metastatic growth of PDAC cells, and to prevent myofibroblast activation, fibrotic stromal expansion, and periostin deposition in vivo, while MAM numbers remained unchanged ( Supplementary  Fig. 8b-e ). To further explore whether this mechanism is specific for the metastatic site, we next analysed primary PDAC tumours for granulin and periostin expression. Interestingly, we found that at the primary tumour site granulin is mainly expressed by tumour cells, and not by macrophages, while periostin was strongly expressed in the surrounding stromal compartment ( Supplementary Fig. 8f ).
Taken together, these data suggest that granulin-expressing macrophages play a critical role at the metastatic site, but not at the primary tumour site.
Circulating IMs from metastatic PDAC patients express granulin
As granulin-expressing MAMs originate from the BM, we next investigated whether circulating IMs express granulin. Therefore, we collected fresh blood samples from PDAC patients with metastases, but before therapeutic intervention, and from healthy control subjects, and purified IMs (CD14 hi CD16 neg ) and resident monocytes (CD14 dim CD16 hi ) by fluorescence-activating cell sorting 45 . We found that the percentage of IMs isolated from metastatic PDAC patients was significantly higher compared with healthy subjects, while no differences were observed in the percentage of resident monocytes (Fig. 8a,b and Supplementary Fig. 8g ). Importantly, IMs isolated from PDAC patients and from metastatic KPC mice exhibited abnormally elevated granulin expression levels compared with healthy control subjects ( Fig. 8c,d ).
DISCUSSION
In this study, we aimed to gain a better understanding of the role of macrophages in pancreatic cancer metastasis, with the hope to improve therapies for this devastating disease. In this respect, we found that MAMs support pancreatic cancer metastasis by secreting granulin, which consequently promotes the activation of resident hStCs into αSMA + myofibroblasts that secrete high levels of periostin ( Fig. 8e) . Collectively, our studies provide a comprehensive functional analysis of stroma-tumour interaction in PDAC metastasis, and support the rationale for the development of therapeutic approaches targeting stromal secreted pro-metastatic factors such as granulin and periostin to disrupt the interrelationship between MAMs, myofibroblasts and cancer cells. In addition, we observed an increase of granulin-expressing IMs in blood from metastatic PDAC patients and metastatic KPC mice compared with healthy subjects. This observation suggests that granulin could also potentially be used as a predictive biomarker of PDAC metastasis. However, to assess the potential use of granulin as a predictive biomarker of PDAC metastasis, granulin expression levels in IMs derived from inflammatory, non-cancerous diseases, such as pancreatitis, would be worth exploring in future analysis.
The fact that MAMs isolated from metastatic lesions secrete high levels of granulin, but resident macrophages (KCs) do not (Fig. 4c) , indicates that the recruitment of monocyte-derived macrophages is a critical step during PDAC metastasis. We and others have previously shown that cancer cells release chemotactic factors, including CCL2, SDF-1α and mCSF1, to attract pro-tumorigenic monocytes to the tumour, in a PI(3)Kγ-dependent manner 11, 35, [46] [47] [48] . Consistent with this, we found that prevention of macrophage recruitment resulted in decreased hStCs activation, reduced periostin levels and decreased metastasis to the liver.
Using an unbiased mass spectrometry secretome analysis of cancereducated macrophages, we identified the glycoprotein granulin. Granulin has previously been associated with fibroblast activation and migration during wound healing 40 . In addition, in breast cancer, granulin expression correlates with increased fibrosis and poor survival 5, 41 . In agreement with a role for granulin in fibrosis, we found that macrophage-secreted granulin plays a critical role in PDAC metastasis by activating resident hStCs and stimulating the secretion of periostin. The precise signalling pathway by which granulin activates hStCs and primary fibroblasts remains unknown, as the cognate cell-surface receptor to which granulin binds is still controversial [49] [50] [51] . Interestingly, depletion of granulin in the haematopoietic compartment did not change macrophage recruitment to the liver, macrophage polarization, or CD8 + T cell infiltration ( Fig. 5 and Supplementary Fig. 7 ).
In agreement with ref. 52 , we found that macrophages play a key role in PDAC metastasis. Whereas ref. 52 describes a role for resident hepatic macrophages in the establishment of a pre-metastatic niche that facilitates initial tumour cells seeding, our work focuses on understanding the subsequent step of metastatic growth. In this respect, we found that once tumour cells have reached the metastatic site, their survival and outgrowth capacity critically depends on the further recruitment of IMs that secrete granulin.
Unfortunately, current imaging approaches are unable to detect micro-metastases and by the time pancreatic cancer patients are diagnosed, micro-metastatic spreading has already occurred in most cases 1 . Our findings suggest that recruitment of IMs that express granulin plays a key role in pancreatic cancer metastasis and may serve both as a prognostic marker, and a potential target for PDAC liver metastasis.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper METHODS Cells. Murine pancreatic cancer cells KPC FC1199, referred to as KPC, were generated in the Tuveson laboratory (Cold Spring Harbor Laboratory, New York, USA) isolated from PDA tumour tissues obtained from Kras G12D/+ ; p53 R172H/+ ; Pdx1-Cre mice of a pure C57BL/6 background as described previously with minor modifications 24 . For some experiments, KPC luc/zsGreen cells were generated by using pHIV Luc-zsGreen (gift from B. Welm, University of Utah, USA, Addgene plasmid no. 39196) lentiviral particle infection. Infected cells were selected for high zsGreen expression levels using a flow cytometry cell sorter (ARIA, BD).
Primary murine hepatic stellate cells were isolated from murine livers of 10-12week-old female C57BL/6 mice according to previously reported protocols 53 . The murine immortalized hepatic stellate cell line from livers of C57BL/6 mice was provided by T. Sakai's laboratory, University of Liverpool, UK 53 . Primary murine dermal fibroblasts were generated as previously described 19 . All fibroblasts were used at an early passage (passage 2-4).
Human primary pancreatic fibroblasts were acquired from Vitro Biopharma, human peripheral blood monocytic cell line THP-1 and human pancreatic cancer cell line PANC1 were acquired from ATCC, and murine C57BL/6 Panc02 pancreatic ductal carcinoma cells were obtained from the NCI DCTD Tumor Repository, NIH.
All cells were cultured in DMEM + 10% FBS and supplemented with 100 units of penicillin, 100 µg ml −1 streptomycin and 2.5 µg ml −1 amphotericin B, except human primary macrophages and THP-1 cells, which were cultured in RPMI + 10% FBS and supplemented with penicillin/streptomycin and amphotericin B.
Primary murine macrophages were generated by flushing the bone marrow from the femur and tibia of C57BL/6 mice followed by incubation for five days in DMEM containing 10% FBS and 10 ng ml −1 murine M-CSF (Peprotech). For some experiments, differentiated macrophages were polarized into an M1, M2 or tumour-educated phenotype using INFγ (20 ng ml −1 , Peprotech) and LPS (100 ng ml −1 , Sigma-Aldrich); IL-4 (20 ng ml −1 , Peprotech); or tumourconditioned media, respectively. Primary human macrophages were generated by purifying CD14+ monocytes from human total blood followed by incubation for five days in RPMI containing 10% FBS and 50 ng ml −1 recombinant human M-CSF (Peprotech). THP-1 cells were incubated with 50 nM phorbol 12myristate 13-acetate for 72 h in RPMI + 10% FBS to generate THP-1-derived macrophages. For some experiments, differentiated primary macrophages or THP-1-derived human macrophages were polarized into an M1, M2 or tumour-educated phenotype using INFγ (50 ng ml −1 , Peprotech) and LPS (10 ng ml −1 , Sigma-Aldrich); IL-4 (40 ng ml −1 , Peprotech); or tumour-conditioned media, respectively.
All cells were routinely tested negative for the presence of mycoplasma contamination. None of the cell lines used in this manuscript is listed in the ICLAC and NCBI Biosample database of misidentified cell lines. Cell lines have been directly purchased from ATTC and NCI DTCP respectively, as described above.
Mice. We obtained transgenic mice lacking PI(3)-kinase γ expression (p110γ −/− ) on the C57BL/6 background 33 from E. Hirsch, Institute of Molecular Biotechnology Center, University of Torino, Italy. Grn −/− mice (B6(Cg)-Grn tm1.1Aidi /J) and tdTomatoRed mice (B6.129(Cg)-Gt(ROSA)26Sor tm4(ACTB-tdTomato,-EGFP)Luo /J) both on the C57BL/6 genetic background were purchased from The Jackson Laboratory. C57BL/6 mice were purchased from Charles River. Kras G12D/+ ; p53 R172H/+ ; Pdx1-Cre mice 24 were purchased from CRUK, Cambridge Research Institute, Cambridge.
All animal experiments were performed in accordance with current UK legislation under an approved project licence PPL 40/3725 (M. Schmid). Mice were housed under specific pathogen-free conditions at the Biomedical Science Unit at the University of Liverpool. In general, for animal studies the group size was calculated by power analysis using a significance level kept at 5% and the power at 80% (according to approved corresponding Home Office Project License Application). For tumour studies, female animals aged 6-8 weeks were used. Animals were randomly assigned to experimental groups. The investigators were not blinded to allocation during experiments and outcome assessments.
Bone marrow transplantation. Bone marrow transplantation was performed by
reconstituting the bone marrow of lethally irradiated (10 Gy) female, 6-week-old C57BL6 mice by tail vein injection of 5 × 10 6 total bone marrow cells isolated from tdTomatoRed mice or Grn −/− mice 35 . After 4 weeks, successful engraftment of tdTomatoRed bone marrow was assessed by flow cytometry. WT recipient mice reconstituted with tdTomatoRed bone marrow showed exclusively tdTomatoRed+ haematopoietic cells, whereas WT recipient mice reconstituted with unlabelled WT bone marrow did not show any tdTomatoRed+ signal. After 4 weeks, engraftment of Grn −/− bone marrow was assessed by genomic DNA PCR according to The Jackson Laboratory protocol on peripheral blood cells from fully recovered bone-marrowtransplanted mice. After confirmation of successful bone marrow reconstitution, mice were enrolled in tumour studies.
Metastasis studies. Experimental liver metastasis was performed by implanting 1 × 10 6 KPC cells or 1 × 10 6 Panc02, respectively, unless otherwise stated, in 20 µl PBS into the spleen of immunocompetent isogenic C57BL/6 mice using a Hamilton 29 G Syringe as previously described 32, 52 . Experimental lung metastasis was performed by injecting 5 × 10 5 KPC cells in 200 µl PBS into the tail vein of immunocompetent isogenic C57BL/6 mice using an insulin syringe. At the indicated time points, mice were euthanized and metastatic tumour burden was assessed by quantifying the frequency and size of metastatic lesions in haematoxylin and eosin-stained paraffin-embedded liver or lung sections by microscopy using ZEN imaging software. Flow cytometry. Single-cell suspensions from murine livers were prepared by mechanical and enzymatic disruption in Hanks balanced salt solution (HBSS) with 1 mg ml −1 collagenase P (Roche) as previously described 55 with some modifications. Briefly, cells in suspension were centrifuged for 5 min at 1,200 r.p.m., resuspended in HBSS and filtered through a 500 µm polypropylene mesh (Spectrum Laboratories). The cell suspension was resuspended in 1 ml 0.05% trypsin and incubated at 37 • C for 5 min. Cells were filtered through a 70 µm cell strainer and resuspended in PBS + 5% BSA. Cells were blocked for 10 min on ice with FC Block (BD Pharmingen, Clone 2.4G2) and then stained with Sytox viability marker (Life Technologies) and fluorochrome-conjugated antibodies (Supplementary Table 5 ). Flow cytometry was performed on a FACSCanto II (BD Biosciences) and FACS performed on a FACSAria (BD Biosciences). For FACS experiments, cells were sorted directly into RLT buffer + β-mercaptoethanol according to the manufacturer's instructions for RNA isolation.
Magnetic bead isolation of cells. Samples for magnetic bead isolation were prepared from livers as described above for preparation of flow cytometry samples. Then samples were stained and PDGFRα+ or F4/80+ cells were isolated according to the manufacturer's instructions (Miltenyi).
Conditioned medium preparation.
Conditioned medium from all cells were generated according to previous reports 56 . Briefly, the medium was removed from 70% confluent cells and the cells were washed three times with PBS before addition of serum-free medium. Cells were incubated for 18-24 h in serum-free medium and then collected and filtered through 0.45 µm filters before use or stored at −20 • C.
Proteomics.
To analyse the secretome of cancer-educated macrophages, THP-1derived human macrophages were stimulated for 24 h with conditioned medium from the human pancreatic cancer cell line PANC1. Cells were then washed three times with PBS and incubated for 24 h in serum-free DMEM. After 24 h of incubation, over 100 ml of cell culture supernatant was collected and filtered through 0.45 µm filters for mass spectrometry. The samples were spiked with 10 µg of human serum albumin (Sigma-Aldrich) as an internal reference and all proteins in each sample were concentrated using MWCO 3kDa Amicon Ultra Centrifugal Filtration Tubes (Millipore) according to the manufacturer's instructions. The protein mixtures were reduced, alkylated, and tryptic-digested as described previously 57 . Each sample was individually labelled with a TMT kit (Thermo Scientific), and then aqueous hydroxylamine solution (5% w/v) was added to quench the reaction. After being combined, labelled peptide samples were vacuum dried, and then dissolved in 0.1% formic acid for LC-MS/MS analysis. The labelled samples were analysed using a two-dimensional LC-MS/MS system consisting of a nanoACQUITY UltraPerformance LC System (Waters) and an LTQ Orbitrap Elite mass spectrometer (Thermo Scientific) equipped with a nano-electrospray source 57 . Briefly, 5 µl aliquots of samples were resolved on a strong cation exchange (5 µm, 3 cm) column, trapped on a C 18 trap column, and then separated on a 200 mm microcapillary C 18 column (particle size 3 µm) packed into 100 µm silica tubing. During the chromatographic separation, the mass spectrometer was operated in a datadependent mode at the voltage of 2 kV with acquisition parameters as follows: five data-dependent CID-HCD dual MS/MS scans per full scan; CID scans acquired with two-microscan averaging; full scans and HCD scans acquired at resolution 60,000 and 15,000 respectively, with two-microscan averaging; 35% normalized collision energy (NCE) in CID and 45% NCE in HCD; ±1 Da isolation window. Previously fragmented ions were excluded for 60 s. Each selected parent ion was first fragmented by CID and then by HCD. MS/MS spectra were analysed against the Uniprot human database (released 18 March 2013). ProLucid 58 was used to identify the peptides with a precursor mass error of 25 ppm and a fragment ion mass error of 600 ppm. TMT modification (+229.1629), carbamidomethylation at cysteine, and oxidation at methionine were considered. For better peptide DOI: 10.1038/ncb3340 identifications and quantifications, six reporter ions were extracted from the HCD spectrum within 0.02 mass tolerance using home-made software and inserted into the corresponding CID spectrum with the same precursor ions 59 . The output data files were filtered and sorted to compose the protein list using DTASelect 60 with ≥2 peptides assignments for a protein identification and a false positive rate ≤0.01.
For quantitative analysis, Census in IP2 pipeline (Integrated Proteomics) was used. Protein abundance was calculated from the average of a reporter ion's intensities from all constituent peptides from a protein 61 . Two different TMT reagents were used to control the quality in quantification, and data with ≥30% variation were excluded. Relative protein abundance was calculated from the ratios of reporter ion intensities.
To identify secreted proteins in the THP-1 macrophages, the full list of identified proteins was analysed using the gene ontology consortium web page for the GO term 'Extracellular Vesicular Exosome' (Gene ontology: tool for the unification of biology 62 ) and then referenced to the Uniprot database (www.uniprot.org) for confirmation.
Dermal fibroblast/hepatic stellate cell activation. Primary PDGFRα+ murine dermal fibroblasts or hepatic stellate cells were isolated as previously described 19, 53 . On the day before stimulation, dermal fibroblasts were washed three times with PBS and then incubated overnight in DMEM + 1%FBS. The next morning, dermal fibroblasts were stimulated with macrophage-conditioned medium (supplemented with 1% FBS) or DMEM + 1%FBS as a control and incubated for 24 h.
Murine hepatic stellate cells were washed three times with PBS and then incubated overnight in DMEM + 2%FBS. The next morning, hepatic stellate cells were stimulated with macrophage-conditioned medium (supplemented with 2% FBS) from WT or Grn −/− macrophages or DMEM + 2%FBS as a control and incubated for 24 h. To rescue the phenotype from Grn −/− macrophage-conditioned medium, Grn −/− MCM were supplemented with recombinant murine progranulin (R&D Systems, 2557-PG-050) at 1 µg ml −1 for activation experiments.
ELISA. Hepatic stellate cells were stimulated with macrophage-conditioned medium (supplemented with 2% FBS) from WT or Grn −/− macrophages or DMEM + 2%FBS as a control and incubated for 24 h. After 24 h, the hepatic stellate cells were washed three times with pre-warmed PBS and then incubated for 48 h in serum-and phenol red-free DMEM. After 48 h, the medium was collected and used for ELISA to measure periostin according to the manufacturer's instructions (R&D Systems, MOSF20). For murine macrophages, cells were stimulated with KPC-or Panc02conditioned medium for 24 h, then washed three times with PBS and incubated in serum-and phenol red-free DMEM. The conditioned medium was collected after 48 h and used for ELISA to measure granulin according to the manufacturer's instructions (LS Bio, LS-F284) Transwell migration assay. Transwell inserts with 8 µm pore size (Corning) were coated with 50 µl growth factor-reduced Matrigel (BD Biosciences) and allowed to solidify. Macrophages were seeded in DMEM + 10%FBS in a 24-well plate. Growth medium was removed, cells were washed three times with PBS, and DMEM + 1% FBS was added. Next, fibroblasts were added in DMEM + 1% FBS into the inserts and allowed to migrate through the insert membrane for 48 h. The inserts were removed, and the inside was swabbed thoroughly with cotton swabs and then fixed in methanol containing 0.05% crystal violet. The number of migrated fibroblasts was counted by bright field microscopy. For Transwell migration of hepatic stellate cells, the hepatic stellate cells were labelled with Vybrant Dil (Life Technology, emission 565) according to the manufacturer's protocol before addition to the inserts. Relative migration was evaluated by the amount of pixels from each condition relative to the pixels from the control using Zen Software.
Proliferation assay. Human primary pancreatic fibroblasts were seeded at a concentration of 2,000 cells per well in 96-well plates in DMEM + 10% FBS. Cells were washed three times with PBS and then stimulated with conditioned medium (supplemented with +1% FBS) prepared from primary human or THP-1 macrophages or DMEM + 1% FBS as a control.
Cell viability was determined by measuring the conversion of water-soluble 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to an insoluble formazan. The concentration of formazan was determined by optical density at 595 nm.
KPC cells were seeded at a concentration of 2,000 cells per well in 96-well plates in DMEM + 10% FBS. Cells were washed three times with PBS and then stimulated with serum-free DMEM as a control or hepatic stellate cellconditioned medium with or without a neutralizing antibody against periostin (R&D Systems, AF2955). Cell viability was determined as described by measuring after 48 and 72 h.
Multicellular colony formation assay. Tumour cells were strained through a 70 µm cell filter to ensure a single-cell suspension. The cells were then embedded at a concentration of 2,000 cells per well in a 0.3% agar mix consisting of either DMEM + 5%FBS (control) or myofibroblast-conditioned medium + 5%FBS. A neutralizing anti-periostin antibody (murine: R&D Systems, AF2955; human: Abcam14041) was incubated for 10 min with the myofibroblast-conditioned medium before embedding into the agar matrix. A layer of control medium or myofibroblastconditioned medium was added on top of the agar matrix with or without the antiperiostin antibody. The colonies were fixed and stained with 0.05% crystal violet in methanol/PBS and the number of colonies per well was counted at day 14 after cell seeding by bright-field microscopy.
RT-qPCR. Cells were lysed in RLT buffer +β-mercaptoethanol according to the manufacturer's instructions for RNA isolation. Total RNA purification was performed with the RNeasy kit and cDNA was generated using QuantiTect Reverse Transcription Kit (Qiagen) according to the manufacturer's instructions. Total RNA (500 ng) was used to generate cDNA. RT-qPCR assays were performed with LightCycler 480 SYBR Green I Master Mix (Roche) on a LightCycler 480 (Roche). Relative expression levels were normalized to Gapdh expression according to the formula 2 −(CT for gene of interest−CT Gapdh) . Fold increase in expression levels was calculated by the comparative C T method 2 − CT (ref. 63) .
Primers are listed in Supplementary Table 4 .
Immunofluorescence. For human tissue sections, antigen retrieval was carried out in high-pH buffer using the Dako PT-Link System. Tissue sections were blocked in PBS + 0.1% bovine serum albumin and 8% normal goat serum prior incubation with primary antibodies. Tissue sections were stained with secondary antibodies including DAPI (Life Technologies) and mounted using Dako Fluorescent Mounting Medium. Murine liver tissues were embedded in Optimal Cutting Temperature (OCT) medium and stored at −80 • C. Tissue sections were fixed in ice-cold acetone, permeabilized with PBS + 0.1% Triton X-100, blocked with PBS + 8% normal goat serum, and incubated with primary antibodies. Next, tissue sections were washed in PBS, stained with secondary antibodies including DAPI (Life Technologies, 1:100) and mounted using Dako Fluorescent Mounting Medium. Goat anti-rat or goat antirabbit secondary antibodies conjugated to AlexaFluor488 and AlexaFluor594 were used (Abcam, 1:500).
Livers from experiments involving ZsGreen/Luciferase-transfected cells were fixed using a sucrose gradient method to preserve the zsGreen fluorescence 64 . All tissue sections were imaged using an Axio Observer Light Microscope with the Apotome.2 (Zeiss) and quantified using the Zen Software (Zeiss). Antibodies are listed in Supplementary Table 5 .
Immunohistochemical analysis. Deparaffinization and antigen retrieval was performed using an automated DAKO PT-link. Paraffin-embedded human and mouse PDA tumours were immunostained using the DAKO envision+ system-HRP. Tissue sections were incubated with primary antibodies followed by HRPconjugated secondary antibody (from DAKO envision kit). Staining was developed using diamino-benzidine and counterstained with haematoxylin. Antibodies are listed in Supplementary Table 5 .
Connective tissue staining (Masson's trichrome staining). Masson's trichrome staining was performed according to the manufacturer's instructions (Abcam ab150686).
Human studies. Human studies using blood samples were approved by the National Research Ethnics (NRES) Service Committee North West-Greater Manchester North 08/H1011/36 and NRES Committee North West-Cheshire 11/NW0083 and REC15/NW/0477. Human blood samples were obtained from advanced PDAC patients with liver metastasis (all pathologically confirmed) or from control healthy subjects. All individuals provided informed consent for blood donation on approved institutional protocols. Blood was collected in sodium heparin (NaH) tubes and immediately processed for mononuclear cell isolation using gradient centrifugation (Histopaque 1077, Sigma-Aldrich) according to the manufacturer's protocol.
Mononuclear cells were resuspended in PBS + 2% BSA and blocked using human TrueStain FcX (Biolegend) following by staining with antibodies and the viability marker SYTOX Green (Life Technologies). Flow cytometry analysis was performed on a FACSCanto II (BD Biosciences) and flow-cytometrybased cell sorting was performed on a FACSAria (BD Biosciences). For cell sorting, cells were sorted directly into RLT buffer +β-mercaptoethanol according to the manufacturer's instructions for RNA isolation (see qPCR section for further details).
Paraffin-embedded human tissue sections from control healthy subjects and advanced PDAC patients with liver metastasis were obtained from the Liverpool Tissue Bank, University of Liverpool, UK or approved by NRES Committee North West -Cheshire REC15/NW/0477. All samples were pathologically confirmed.
Statistics and reproducibility.
The level of significance was determined by a twotailed unpaired Student's t-test and analysed with GraphPad Prism5 software. P < 0.05 was considered significant.
Immunohistochemical and immunofluorescence analyses of human healthy and metastatic liver biopsies (Figs 1a, 4e, 6d and Supplementary Fig. 1a -c) are shown from n = 5 healthy subjects and n = 5 metastatic patients, and human primary PDAC tumour ( Supplementary Fig. 8f ) n = 4. Images were acquired and analysed using five different visual fields from each tissue section. For immunohistochemical and immunofluorescence analysis of murine tissue sections, the following numbers of different visual fields from each tissue section were analysed: Supplementary  Fig. 4e (2 fields) ; Supplementary Fig. 3d (3 fields); Figs 1c,d,f, 2d, 5d ,h and 7d,e (4 fields); Figs 2f, 4d, 5j,k and 6d, and Supplementary Figs 5e and 8a ,c-e (5 fields), Supplementary Figs 6f and 7e (8 fields) . For Figs 2b,c,g,h and 5b ,c,f,g, and Supplementary Figs 4c,d, 5f ,g and 8b all metastatic nodules were counted and measured (size) within one liver section. Numbers of different samples used to acquire images are reported in the corresponding figure legends. Transwell migration assays (Fig. 3b,d) are shown as the mean from n = 3 independent experiments. For each experiment, 10 different visual fields per condition were counted. Colony formation assays (Fig. 6c ) are shown as the mean from n = 3 independent experiments; total number of colonies per cell type per experiment was counted. qPCR analysis (Fig. 3a ,c,f and Supplementary Figs 6d,e and 7d ) are shown as the mean from n = 3 independent experiments. qPCR analyses of in vivo-derived murine cells are shown as the mean from three technical replicates whereby samples were pooled from several animals from each condition: Figs 4a,c and 5e (three pooled mice); Fig. 8d (four pooled mice), Fig. 5i (five pooled mice), Figs 5l and 7f (six pooled mice); qPCR analyses of in vivo-derived human cells are shown as mean from n = 3 healthy and n = 4 PDAC patients (Fig. 8c ). ELISA analyses (Figs 3g, 4b and 7c ) are shown as the mean from n = 3 independent experiments, whereby two (Figs 4b and 7c) and three (Fig. 3g) Supplementary Figure 6 High levels of granulin are specifically expressed by tumour educated macrophages in vitro and in vivo. (a) Quantification of aSMA (Acta2) and collagen 1a (Col1a) mRNA levels in primary murine dermal fibroblasts stimulated with isogenic macrophage conditioned media (CM) as determined by qPCR. Bar graph show fold up regulation compared to unstimulated and are displayed as mean (data are from a single experiment, repeated four times with similar results; Supplementary  Table 6 ). (b) Quantification of human (green) and mouse (red) myofibroblast that migrated towards human and mouse macrophages, respectively, in a matrigel-coated transwell assay (n = 4 independent experiments; mean ± s.e.m.; two-tailed unpaired t-test) (c) Quantification of human myofibroblast proliferation in the presence of control media, THP-1 derived macrophage CM, or primary macrophage CM (n = 4 independent experiments; mean ± s.e.m.; two-tailed unpaired t-test). (d) Quantification of granulin mRNA expression levels by qPCR in human primary unstimulated macrophages (M0) or primary macrophages stimulated with either interleukin (IL) -4 (M2-like phenotype), interferon (IFN) g / LPS (M1-like phenotype) or educated with tumour conditioned media generated from human Panc1 cells (n = 3 independent experiments mean ± s.e.m.; two-tailed unpaired t-test). (e) Quantification of granulin mRNA expression levels by qPCR in murine primary macrophages stimulated with either interleukin (IL) -4 (M2-like phenotype), interferon (IFN) g / LPS (M1-like phenotype) or educated with tumour conditioned media generated from murine KPC and Panc02 PDAC cancer cells (n = 3 independent experiments; mean ± s.e.m; two-tailed unpaired t-test). (f) Metastatic hepatic tumours derived from the spontaneous mouse pancreatic cancer model Pdx1Cre-ERT;Kras G12D ;Trp53 R172H ; (PdxCre-ERT KP mice) were isolated and morphometrically analysed. Representative images of immunohistochemistry staining for MAMs (CD68+) and granulin expression on serial tissue sections from metastatic lesions and healthy liver and quantification of the data (n = 1 mouse per condition; eight fields assessed per sample; bars represent means). ns, not significant. 
